Infrapatellar bursal injection with dextrose and saline are both effective treatments for Osgood–Schlatter disease. Letter to editor for: No superiority of dextrose injections over placebo injections for Osgood–Schlatter disease: a prospective randomized double‑blind study https://doi.org/10.1007/s00402-019-03297-2

2020 ◽  
Vol 140 (4) ◽  
pp. 591-592
Author(s):  
David Rabago ◽  
Kenneth Dean Reeves ◽  
Gastón Andrés Topol ◽  
Leandro Ariel Podesta ◽  
An-Lin Cheng ◽  
...  
Keyword(s):  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Effective Treatments

The Nottingham ECT Study

1985 ◽  
Vol 146 (5) ◽  
pp. 520-524 ◽  
Author(s):  
S. Gregory ◽  
C. R. Shawcross ◽  
D. Gill
Keyword(s):  
Clinical Practice ◽  
Depressive Illness ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Highly Effective ◽  
Effective Treatments

SummarySixty nine patients took part in a double-blind study to investigate the efficacy of bilateral, unilateral, and simulated ECT in the treatment of depressive illness. The findings suggest that both bilateral and unilateral ECT are highly effective treatments for depression and are significantly superior to simulated ECT. There was also evidence that patients receiving bilateral ECT recovered more rapidly than those receiving unilateral ECT and required significantly fewer treatments. The relevance of these findings to clinical practice is discussed.

Double-Blind Study of Antihistaminic Drugs

1973 ◽  
Vol 35 (5) ◽  
pp. 627-633
Author(s):  
Masayuki SHIMIZU ◽  
Yoshiko HIDAKA ◽  
Ryuhji TAKEUCHI
Keyword(s):  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Antihistaminic Drugs

OnabotulinumtoxinA for Treatment of Moderate-to-Severe Horizontal Lines and Glabellar Lines from the Subject's Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study

2017 ◽  
Vol 1 ◽  
pp. s82
Author(s):  
Steven Dayan ◽  
Patricia Ogilvie ◽  
Alexander Z Rivkin ◽  
Steven G Yoelin ◽  
Julie K Garcia ◽  
...  
Keyword(s):  
Blind Study ◽  
Double Blind Study ◽  
Phase 3 ◽  
Double Blind ◽  
Patient Reported

Abstract Not Available Disclosures: Study supported by Allergan.

Sign in / Sign up

Export Citation Format

Share Document